Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

New understanding and treatments for hair loss are improving, but more research is needed.

Intermittent compression therapy is safe and doesn't harm tissue.

PADs are crucial for healthy skin and hair, and their imbalance can cause skin and hair disorders.

Dermoscopy is an effective tool for accurately detecting skin cancers.

Noninvasive scalp imaging techniques can improve patient care by reducing the need for biopsies.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Exosome therapy could be a promising new way to treat hair loss.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Sebaceous gland atrophy and inflammation may cause hair loss in psoriasis.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.